News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,203 Results
Type
Article (40570)
Company Profile (255)
Press Release (669368)
Multimedia
Podcasts (70)
Webinars (15)
Section
Business (204555)
Career Advice (2028)
Deals (35495)
Drug Delivery (99)
Drug Development (81325)
Employer Resources (173)
FDA (16326)
Job Trends (14930)
News (346102)
Policy (32718)
Tag
Academia (2561)
Accelerated approval (14)
Adcomms (24)
Allergies (109)
Alliances (49613)
ALS (125)
Alzheimer's disease (1520)
Antibody-drug conjugate (ADC) (170)
Approvals (16373)
Artificial intelligence (352)
Autoimmune disease (39)
Automation (23)
Bankruptcy (361)
Best Places to Work (11643)
BIOSECURE Act (19)
Biosimilars (133)
Biotechnology (174)
Bladder cancer (111)
Brain cancer (39)
Breast cancer (408)
Cancer (3290)
Cardiovascular disease (267)
Career advice (1699)
Career pathing (32)
CAR-T (203)
CDC (37)
Cell therapy (545)
Cervical cancer (27)
Clinical research (67530)
Collaboration (1175)
Company closure (4)
Compensation (832)
Complete response letters (37)
COVID-19 (2661)
CRISPR (66)
C-suite (473)
Cystic fibrosis (120)
Data (3672)
Decentralized trials (2)
Denatured (22)
Depression (79)
Diabetes (386)
Diagnostics (6488)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (162)
Drug pricing (136)
Drug shortages (28)
Duchenne muscular dystrophy (171)
Earnings (88545)
Editorial (44)
Employer branding (22)
Employer resources (149)
Events (114648)
Executive appointments (889)
FDA (18454)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1041)
Gene editing (146)
Generative AI (25)
Gene therapy (430)
GLP-1 (837)
Government (4581)
Grass and pollen (5)
Guidances (330)
Healthcare (18854)
HIV (42)
Huntington's disease (31)
IgA nephropathy (47)
Immunology and inflammation (185)
Immuno-oncology (13)
Indications (45)
Infectious disease (2853)
Inflammatory bowel disease (162)
Inflation Reduction Act (10)
Influenza (77)
Intellectual property (156)
Interviews (319)
IPO (16612)
IRA (48)
Job creations (3655)
Job search strategy (1432)
Kidney cancer (13)
Labor market (63)
Layoffs (525)
Leadership (22)
Legal (7956)
Liver cancer (85)
Longevity (11)
Lung cancer (477)
Lymphoma (244)
Machine learning (22)
Management (58)
Manufacturing (504)
MASH (106)
Medical device (13558)
Medtech (13575)
Mergers & acquisitions (19682)
Metabolic disorders (943)
Multiple sclerosis (111)
NASH (16)
Neurodegenerative disease (155)
Neuropsychiatric disorders (38)
Neuroscience (2324)
NextGen: Class of 2025 (6525)
Non-profit (4495)
Now hiring (53)
Obesity (462)
Opinion (235)
Ovarian cancer (111)
Pain (136)
Pancreatic cancer (141)
Parkinson's disease (198)
Partnered (24)
Patents (362)
Patient recruitment (259)
Peanut (53)
People (58067)
Pharmaceutical (62)
Pharmacy benefit managers (21)
Phase I (21004)
Phase II (29741)
Phase III (22152)
Pipeline (2377)
Policy (231)
Postmarket research (2569)
Preclinical (8949)
Press Release (64)
Prostate cancer (161)
Psychedelics (39)
Radiopharmaceuticals (255)
Rare diseases (520)
Real estate (5934)
Recruiting (67)
Regulatory (23137)
Reports (51)
Research institute (2340)
Resumes & cover letters (351)
Rett syndrome (11)
RNA editing (11)
RSV (55)
Schizophrenia (106)
Series A (171)
Series B (128)
Service/supplier (11)
Sickle cell disease (68)
Special edition (19)
Spinal muscular atrophy (149)
Sponsored (34)
Startups (3601)
State (2)
Stomach cancer (14)
Supply chain (86)
Tariffs (72)
The Weekly (46)
Vaccines (864)
Venture capital (59)
Weight loss (289)
Women's health (51)
Worklife (17)
Date
Today (106)
Last 7 days (422)
Last 30 days (2214)
Last 365 days (30863)
2025 (21573)
2024 (35235)
2023 (40091)
2022 (51199)
2021 (55732)
2020 (54099)
2019 (46577)
2018 (35052)
2017 (32150)
2016 (31509)
2015 (37568)
2014 (31334)
2013 (26378)
2012 (28602)
2011 (29309)
2010 (27345)
Location
Africa (729)
Alabama (69)
Alaska (7)
Arizona (258)
Arkansas (13)
Asia (38493)
Australia (6287)
California (8525)
Canada (2635)
China (772)
Colorado (356)
Connecticut (362)
Delaware (224)
Europe (82861)
Florida (1273)
Georgia (285)
Hawaii (2)
Idaho (60)
Illinois (680)
India (38)
Indiana (402)
Iowa (17)
Japan (260)
Kansas (114)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1132)
Massachusetts (6233)
Michigan (264)
Minnesota (504)
Mississippi (4)
Missouri (101)
Montana (28)
Nebraska (25)
Nevada (98)
New Hampshire (68)
New Jersey (2328)
New Mexico (28)
New York (2313)
North Carolina (1189)
North Dakota (8)
Northern California (3862)
Ohio (261)
Oklahoma (16)
Oregon (35)
Pennsylvania (1800)
Puerto Rico (17)
Rhode Island (41)
South America (1102)
South Carolina (43)
South Dakota (1)
Southern California (3277)
Tennessee (138)
Texas (1312)
United States (31035)
Utah (252)
Virginia (210)
Washington D.C. (74)
Washington State (706)
West Virginia (4)
Wisconsin (71)
710,203 Results for "genentech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immuno-oncology
Genentech Walks Away From $2B Partnership With Adaptive Biotechnologies
Adaptive and Genentech first partnered in 2018 to advance T cell receptor-based therapies for cancer.
August 19, 2025
·
1 min read
·
Tristan Manalac
Layoffs
Genentech Downsizes by 87 as Priorities Shift
The latest round of terminations, which will take effect Sept. 15, comes after Genentech fired more than 500 employees in the last 15 months.
July 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
New Data for Genentech’s Vabysmo Reinforce Its Efficacy, Safety and Durability in Wet Age-Related Macular Degeneration (AMD)
September 5, 2025
·
9 min read
Deals
Genentech Offers up to $765M in Biobucks to Repertoire for I&I Drug Discovery
Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new targets for an undisclosed autoimmune disorder.
April 23, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Genentech’s Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD)
August 3, 2025
·
13 min read
Press Releases
FDA Approves Genentech’s Susvimo for Diabetic Retinopathy
May 23, 2025
·
12 min read
Press Releases
OMass Therapeutics Enters into Exclusive Collaboration and License Agreement with Genentech to Develop and Commercialize Therapies for Inflammatory Bowel Disease
September 2, 2025
·
3 min read
Press Releases
Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension
September 1, 2025
·
11 min read
Press Releases
Genentech Provides Update on Astegolimab in Chronic Obstructive Pulmonary Disease
July 21, 2025
·
3 min read
Press Releases
Genentech and Roche Break Ground on State-of-the-Art Manufacturing Facility in Holly Springs, North Carolina
August 26, 2025
·
4 min read
1 of 71,021
Next
